Severe community-acquired pneumonia: current management and future therapeutic alternatives

J Garnacho-Montero, I Barrero-Garcia… - Expert review of anti …, 2018 - Taylor & Francis
Introduction: Despite advances in modern medicine, severe community-acquired
pneumonia (CAP) continues to be a potentially deadly disease. Mortality rate reaches up to …

Urinary antigen testing for respiratory infections: current perspectives on utility and limitations

P Kim, A Deshpande, MB Rothberg - Infection and drug resistance, 2022 - Taylor & Francis
Pneumonia is a leading cause of hospitalization and death due to infection worldwide.
Streptococcus pneumoniae and Legionella pneumophila remain among the most commonly …

[HTML][HTML] A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

C Bahrs, M Kesselmeier, M Kolditz… - European …, 2022 - Eur Respiratory Soc
Pneumococcal infections are globally the most frequent vaccine-preventable cause of death
[1], and community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae is the …

[HTML][HTML] The evolution of rapid antigen detection systems and their application for COVID-19 and other serious respiratory infectious diseases

CS Pavia, MM Plummer - Journal of Microbiology, Immunology and …, 2021 - Elsevier
Making the correct diagnosis of a patient seeking medical attention is the ultimate goal of a
practicing physician, irrespective of whether the cause of the patient's condition is infectious …

Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia

C Forstner, M Kolditz, M Kesselmeier, S Ewig, G Rohde… - Vaccine, 2020 - Elsevier
Introduction Implementation of the 7-valent pneumococcal conjugate vaccine (PCV7) in
infant vaccination programs has substantially reduced the burden of PCV7 serotypes also in …

Prevalence of pneumococcal serotypes in community-acquired pneumonia among older adults in Italy: a multicenter cohort study

A Orsi, A Domnich, S Mosca, M Ogliastro, L Sticchi… - Microorganisms, 2022 - mdpi.com
Pneumococcal community-acquired pneumonia (CAP) is a leading cause of mortality.
Following the introduction of pneumococcal conjugate vaccines (PCVs) in children, a …

Urinary antigen testing in community-acquired pneumonia in adults: an update

D Viasus, L Calatayud, MV McBrown… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: Community-acquired pneumonia (CAP) continues to be a leading cause of
hospitalization and mortality worldwide. Streptococcus pneumoniae and Legionella …

Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis

L Lansbury, B Lim, TM McKeever, H Lawrence… - …, 2022 - thelancet.com
Background Non-invasive pneumococcal pneumonia causes significant morbidity and
mortality in older adults. Understanding pneumococcal sero-epidemiology in adults≥ 50 …

Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?

C Hyams, OM Williams, P Williams - ERJ Open Research, 2020 - Eur Respiratory Soc
Microbiological confirmation of pneumonia caused by Streptococcus pneumoniae remains
challenging as culture from blood or pleural fluid is positive in only 15–30% cases. It was …

Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia

LA Ruiz, L Serrano, S Pérez, S Castro, A Urrutia… - Infection, 2023 - Springer
Purpose To evaluate the impact of an optimal and reproducible cutoff value set according to
a predefined lymphopenia scale as an early predictor of in-hospital mortality and other …